EXPORT CITATION

Chapter-31 Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

BOOK TITLE: Year Book of Medicine 2019

Author
1. Jindal Surinder K
2. Krishnaswamy Uma Maheswari
3. Valliappan M
ISBN
9789389188738
DOI
10.5005/jp/books/18366_33
Edition
1/e
Publishing Year
2019
Pages
2
Author Affiliations
1. Postgraduate Institute of Medical Education and Research, Chandigarh, India, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India, Jindal Clinic, Chandigarh, India, Post Graduate Institute of Medical Education and Research, Chandigarh, India, Jindal Clinics; Postgraduate Institute of Medical Education and Research, Chandigarh, India, Jindal Clinics; PGIMER, Chandigarh, India
2. Medicine, St. Johns National Academy of Health Sciences, Bengaluru, Karnataka, India
3. Postgraduate Institute of Medical Education and Research, Chandigarh, India
Chapter keywords
Durvalumab, chemoradiotherapy, progression free survival, overall survival, confidence interval, distant metastasis, hazard ratio, Nonsmall-cell lung cancer, NSCLC, biomarker

Abstract

Related Books

© 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved